# Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.

> **NCT01825577** · PHASE4 · TERMINATED · sponsor: **St. Louis University** · enrollment: 14 (actual)

## Conditions studied

- Dementia
- Accidental Falls
- Apathy

## Interventions

- **DRUG:** Transdermal Methylphenidate

## Key facts

- **NCT ID:** NCT01825577
- **Lead sponsor:** St. Louis University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Administrative Reasons
- **Last updated:** 2018-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01825577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01825577, "Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01825577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*